Viewing Study NCT03182894

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-01-09 @ 5:59 AM
Study NCT ID: NCT03182894
Status: WITHDRAWN
Last Update Posted: 2018-08-28
First Post: 2017-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer
Sponsor: James J Lee
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chemo-refractory View
None pembrolizumab View
None epacadostat View
None azacitidine View
None recommended phase 2 dose (RP2D) View
None microsatellite-stable (MSS) Metastatic Colorectal Cancer View